ARTICLE | Clinical News
Cx501 regulatory update
June 19, 2006 7:00 AM UTC
EMEA granted Orphan Drug designation to Cx501 to treat epidermolysis bullosa (EB), a rare, genetically inherited disease, in which the patient is unable to produce collagen VII, resulting in blisteri...